北美ivd 管理事务外包市场趋势、规模和分析

北美 IVD 监管事务外包市场，按服务（监管撰写与提交、监管注册与临床试验申请、监管咨询、法律代表、数据管理服务、化学制造与控制 (CMC) 服务及其他）、适应症（肿瘤学、神经病学、心脏病学、临床化学和免疫测定、精准医疗、传染病、糖尿病、基因检测、艾滋病毒/艾滋病、血液学、药物检测/药物基因组学、输血、护理点及其他）、部署模式（云和本地）、组织规模（中小型企业 (SMES) 和大型企业）、阶段（临床、临床前和 PMA（上市后授权））、类别（I 类、II 类和 III 类）、最终用户（制药公司、医疗器械公司、生物技术公司等）、国家（美国、加拿大、墨西哥）行业趋势和预测到 2029 年。

市场分析和见解: 北美IVD管理事务外包市场

北美IVD监管事务外包市场预计将在2022至2029年的预测期内获得市场增长. 数据桥市场研究分析认为,在2022至2029年的预测期内,市场正在增长,CAGR为13.4%,预计到2029年将达到779,587.15万美元。

体外诊断产品是用于诊断疾病或其他情况的试剂、装置和系统,包括确定一个人的健康状况,以治疗、减轻、治疗或预防疾病。这些产品旨在用于人体标本的收集、准备和检查。监管事务在体外诊断器械(IVD)和医疗器械行业中发挥着至关重要的作用. 监管事务外包服务涉及为临床研究项目提供高质量文件的专业人员撰写和出版监管文件。在新兴经济体进行的临床研究中,对监管服务外包的需求正在大幅增加,为这一行业的增长提供了一个健康的平台。

推动IVD监管事务外包市场增长的主要因素是发展基于项目的支持,导致组织之间达成长期外包协议,以及各种体外诊断设备的技术进步. 整个区域的公司研发活动的增加为市场的增长创造了机会。 IVD的维护和外包成本较高,是IVD管理事务外包市场的主要制约因素。缺乏处理体外诊断装置的熟练人员是市场增长的一大挑战。

本IVD监管事务外包市场报告详细介绍了市场份额,新发展,以及产品管线分析,国内和地方化市场主体的影响,分析新兴收益口袋,市场监管变化,产品审批,战略决策,产品推出,地域扩张,市场技术创新等方面的机会. 为了了解分析和市场状况联系我们分析员简介我们的团队将帮助你创造收入影响解决方案实现你期望的目标

北美IVD 监管事务外包市场范围和市场规模

北美IVD管理事务外包市场分为七个值得注意的部分,这些部分基于服务、指示、部署模式、组织规模、舞台、类别和最终用户。

基于服务,北美四.D监管事务外包市场分为监管书写和提交、监管登记和临床试验应用、监管咨询、法律代表、数据管理服务、化学制造和控制服务等。 2022年,由于该行业正在应对一些广泛的发展,引发了IVD技术的革新和扩展,预计监管写作和提交将主导市场. 这些大规模的趋势包括人口老化,传染病的发生增加,大技术革新者的影响和接受个性化护理,并渴望方便使用.
根据说明,北美IVD监管事务外包市场分为肿瘤学,神经学,心脏病学,临床化学和免疫学,精密医学,传染病,糖尿病,遗传检测,艾滋病毒/艾滋病,血液学,药物检测/药物基因组学,血迹输血,护理点等等 2022年,肿瘤部分预计将占据主导地位,因为它提高了肿瘤药物开发过程的可预测性,成为肿瘤学家在决定患者治疗计划时的有用工具.
根据部署模式,北美IVD监管事务外包市场被分割成云和地壳. 2022年,云段预计将占据主导地位,因为它在IVD监管中的Cloud计算技术因其具有成本效益和解决方案灵活性,为IVD系统交易公司提供了稳定的基础设施,最大输出.
根据组织规模,北美IVD监管事务外包市场被划分为中小企业(SMES)和大型企业. 2022年,由于大企业部门参与与IVD监管相关的同行高品质技术和服务组合,预计将占据主导地位.
在阶段的基础上,北美IVD监管事务外包市场被划分为临床,临床前,和PMA(市场后授权). 2022年,由于临床试验需要当局批准,预计临床部分会占据市场主导地位,每一次结果都必须在提交前归档并全面记录,监管事务服务在这一领域的需求很高.
以分级为基础,北美IVD监管事务外包市场分为一等,二等,三级. 2022年,一级部门预计将主导市场,因为它不涉及公共卫生风险或低个人风险,监管最低。这些医疗器械的需求很大,47%的医疗器械属于这一类别。
在最终用户的基础上,北美IVD监管事务外包市场被分割成制药公司,医疗器械公司,生物技术公司等. 2022年,医疗器械公司预计将通过出现各种高效的技术服务和标准来主导市场.

北美IVD 监管事务外包市场

北美IVD监管事务外包市场分析,市场规模信息由国家,服务,指示,部署模式,组织规模,舞台,类和终端用户提供.

北美IVD监管事务外包市场报告覆盖的国家有美国,墨西哥和加拿大.

由于保健部门新技术的日益发展以及各组织的战略收购和伙伴关系,美国正在北美地区主导市场。

报告的国家部分还介绍了影响市场的因素和国内市场监管的变化,这些因素和变化影响到市场目前和未来的趋势。新的销售、替代销售、国家人口统计、管制条例和进出口关税等数据点是用来预测个别国家市场情况的一些主要指针。此外,考虑到全球品牌的存在和可得性及其由于来自当地和国内品牌的大规模或稀缺竞争而面临的挑战,在对国家数据进行预测分析的同时,还考虑了销售渠道的影响。

IVD管理事务外包需求增加

北美IVD监管事务外包市场也为你们提供了详细的市场分析,说明每个国家的工业增长情况,销售额,部件销售额,IVD监管事务外包的技术发展影响,以及它们支持IVD监管事务外包市场的监管方案的变化. 现有2012年至2020年历史时期的数据。

竞争性景观和北美IVD管理事务外包市场份额分析

北美IVD监管事务外包市场竞争性景观提供竞争对手的详细信息. 详细情况包括:公司概况,公司财务,创收,市场潜力,研发投资,新市场举措,全球存在,生产地和设施,公司优势和弱点,产品推出,产品试验管线,产品审批,专利,产品宽度和广度,应用优势,技术命脉曲线等. 上述数据点仅与北美IVD管理事务外包市场有关的公司重点有关。

报告内的一些主要参与者是IVD监管事务外包市场:Freyr Solutions,AX Source,LORENZ生命科学集团,PPD Inc.(Thremofisher Science Inc.的子公司),Promedica International,加州一家公司,Assent Reference Inc.,MakroCare,EMERGO,ICON, Parexel International Corporation, CRITERIUM,INC., Groupe Proparmamarma Group, VCLS, Labcorp Drug Drug Developy, WuXi AppTec, Charles River Laboratories, Genpat, Medpache, 监管合规联营公司,RQM+,萨拉卡解决方案私人有限公司,PBC BioMed,多尔制药服务公司,Qservere,mdiconfants等. DBMR分析师了解竞争优势,为每个竞争者分别提供竞争分析.

世界各地的公司也发起了许多产品开发,也正在加速北美IVD管理事务外包市场的增长。

比如说,

2021年9月,塔奈斯特宣布为ICON plc提供数百万欧元研发支持,以加速分散临床试验技术. Tánaiste兼企业、贸易和就业部长Leo Varadkar TD宣布,ICON plc(纳斯达克:ICLR)是设在都柏林的制药、生物技术和医疗器械工业药物开发和商业化服务的全球供应商,已获得400万美元的研发支助,由爱尔兰企业管理,以进一步加强其数据解决方案和分散临床试验技术。这有助于公司改善其在市场中的地位。
2021年10月,Proparma集团收购了Pharmica Consult. ProPharma Group是奥德赛投资伙伴公司(Odyssey Investment Partners)的一家投资组合公司,已经收购了Pharmica Consultation,一家生命科学咨询公司,为制药和生物技术公司提供项目管理(PM)咨询解决方案和专有业务软件,以进行临床试验. 这帮助了公司在全球市场扩展业务.

伙伴关系、合资企业和其他战略提高了公司的市场份额,增加了覆盖面和存在。它还为组织通过扩大规模改进对IVD管理事务外包的报价提供了好处。

SKU-67919

在线获取全球首个市场情报云平台的报告访问权限

点击图片放大

交互式数据分析仪表板
用于发现高增长潜力机会的公司分析仪表板
研究分析师支持（定制与咨询）
带有交互式仪表板的竞争对手分析
最新新闻、更新与趋势分析
利用基准分析的强大功能，实现全面的竞争对手跟踪

申请演示

表格列表

TABLE 1 NORTH AMERICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY SERVICE, 2020-2029 (USD THOUSAND)

TABLE 2 NORTH AMERICA REGULATORY WRITING & SUBMISSIONS IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (USD THOUSAND)

TABLE 3 NORTH AMERICA LEGAL REPRESENTATION IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (USD THOUSAND)

TABLE 4 NORTH AMERICA REGULATORY CONSULTING IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (USD THOUSAND)

TABLE 5 NORTH AMERICA REGULATORY REGISTRATION & CLINICAL TRIAL APPLICATIONS IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (USD THOUSAND)

TABLE 6 NORTH AMERICA CHEMISTRY MANUFACTURING AND CONTROLS (CMC) SERVICES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (USD THOUSAND)

TABLE 7 NORTH AMERICA DATA MANAGEMENT SERVICES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY MATERIAL, 2020-2029 (USD THOUSAND)

TABLE 8 NORTH AMERICA OTHERS IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (USD THOUSAND)

TABLE 9 NORTH AMERICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY INDICATION, 2020-2029 (USD THOUSAND)

TABLE 10 NORTH AMERICA CLINICAL CHEMISTRY AND IMMUNOASSAYS IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (USD THOUSAND)

TABLE 11 NORTH AMERICA INFECTIOUS DISEASES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION,2020-2029 (THOUSAND)

TABLE 12 NORTH AMERICA INFECTIOUS DISEASES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY TYPE, 2020-2029 (USD THOUSAND)

TABLE 13 NORTH AMERICA HAEMATOLOGY IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (USD THOUSAND)

TABLE 14 NORTH AMERICA DRUG TESTING/PHARMACOGENOMICS IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (THOUSAND)

TABLE 15 NORTH AMERICA PRECISION MEDICINE IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (THOUSAND)

TABLE 16 NORTH AMERICA DIABETES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (THOUSAND)

TABLE 17 NORTH AMERICA BLOOD TRANSFUSION IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (THOUSAND)

TABLE 18 NORTH AMERICA CARDIOLOGY IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (THOUSAND)

TABLE 19 NORTH AMERICA POINT OF CARE IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (THOUSAND)

TABLE 20 NORTH AMERICA POINT OF CARE IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY TYPE, 2020-2029 (USD THOUSAND)

TABLE 21 NORTH AMERICA ONCOLOGY IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (THOUSAND)

TABLE 22 NORTH AMERICA NEUROLOGY IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (THOUSAND)

TABLE 23 NORTH AMERICA HIV/AIDS IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (THOUSAND)

TABLE 24 NORTH AMERICA GENETIC TESTING IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (THOUSAND)

TABLE 25 NORTH AMERICA OTHERS IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (THOUSAND)

TABLE 26 NORTH AMERICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY CLASS, 2020-2029 (USD THOUSAND)

TABLE 27 NORTH AMERICA CLASS I IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (USD THOUSAND)

TABLE 28 NORTH AMERICA CLASS III IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (THOUSAND)

TABLE 29 NORTH AMERICA CLASS II IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (USD THOUSAND)

TABLE 30 NORTH AMERICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY DEPLOYMENT MODE, 2020-2029 (USD THOUSAND)

TABLE 31 NORTH AMERICA CLOUD IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (USD THOUSAND)

TABLE 32 NORTH AMERICA ON-PREMISES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (USD THOUSAND)

TABLE 33 NORTH AMERICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY DEPLOYMENT MODE, 2020-2029 (USD THOUSAND)

TABLE 34 NORTH AMERICA LARGE ENTERPRISES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (USD THOUSAND)

TABLE 35 NORTH AMERICA SMALL & MEDIUM ENTERPRISES (SMES) IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (USD THOUSAND)

TABLE 36 NORTH AMERICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY STAGE, 2020-2029 (USD THOUSAND)

TABLE 37 NORTH AMERICA CLINICAL IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (USD THOUSAND)

TABLE 38 NORTH AMERICA PRECLINICAL IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (USD THOUSAND)

TABLE 39 NORTH AMERICA PMA (POST MARKET AUTHORIZATION) IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (USD THOUSAND)

TABLE 40 NORTH AMERICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY END USER, 2020-2029 (USD THOUSAND)

TABLE 41 NORTH AMERICA MEDICAL DEVICE COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (USD THOUSAND)

TABLE 42 NORTH AMERICA MEDICAL DEVICE COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY ORGANIZATION SIZE, 2020-2029 (USD THOUSAND)

TABLE 43 NORTH AMERICA MEDICAL DEVICE COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY SERVICE, 2020-2029 (USD THOUSAND)

TABLE 44 NORTH AMERICA PHARMACEUTICAL COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (USD THOUSAND)

TABLE 45 NORTH AMERICA PHARMACEUTICAL COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY ORGANIZATION SIZE, 2020-2029 (USD THOUSAND)

TABLE 46 NORTH AMERICA PHARMACEUTICAL COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY SERVICE, 2020-2029 (USD THOUSAND)

TABLE 47 NORTH AMERICA BIOTECHNOLOGY COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (USD THOUSAND)

TABLE 48 NORTH AMERICA BIOTECHNOLOGY COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY ORGANIZATION SIZE, 2020-2029 (USD THOUSAND)

TABLE 49 NORTH AMERICA BIOTECHNOLOGY COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY SERVICE, 2020-2029 (USD THOUSAND)

TABLE 50 NORTH AMERICA OTHERS IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY REGION, 2020-2029 (USD THOUSAND)

TABLE 51 NORTH AMERICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY COUNTRY, 2020-2029 (USD THOUSAND)

TABLE 52 NORTH AMERICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY SERVICE, 2020-2029 (USD THOUSAND)

TABLE 53 NORTH AMERICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY INDICATION, 2020-2029 (USD THOUSAND)

TABLE 54 NORTH AMERICA INFECTIOUS DISEASES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY TYPE, 2020-2029 (USD THOUSAND)

TABLE 55 NORTH AMERICA POINT OF CARE IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY TYPE, 2020-2029 (USD THOUSAND)

TABLE 56 NORTH AMERICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY DEPLOYMENT MODE, 2020-2029 (USD THOUSAND)

TABLE 57 NORTH AMERICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY ORGANIZATION SIZE, 2020-2029 (USD THOUSAND)

TABLE 58 NORTH AMERICA REGULATORY AFFAIRS OUTSOURCING MARKET, BY STAGE, 2020-2029 (USD THOUSAND)

TABLE 59 NORTH AMERICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY CLASS, 2020-2029 (USD THOUSAND)

TABLE 60 NORTH AMERICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY END USER, 2020-2029 (USD THOUSAND)

TABLE 61 NORTH AMERICA MEDICAL DEVICE COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY ORGANIZATION SIZE, 2020-2029 (USD THOUSAND)

TABLE 62 NORTH AMERICA MEDICAL DEVICE COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY SERVICE, 2020-2029 (USD THOUSAND)

TABLE 63 NORTH AMERICA PHARMACEUTICAL COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY ORGANIZATION SIZE, 2020-2029 (USD THOUSAND)

TABLE 64 NORTH AMERICA PHARMACEUTICAL COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY SERVICE, 2020-2029 (USD THOUSAND)

TABLE 65 NORTH AMERICA BIOTECHNOLOGY COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY ORGANIZATION SIZE, 2020-2029 (USD THOUSAND)

TABLE 66 NORTH AMERICA BIOTECHNOLOGY COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY SERVICE, 2020-2029 (USD THOUSAND)

TABLE 67 U.S. IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY SERVICE, 2020-2029 (USD THOUSAND)

TABLE 68 U.S. IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY INDICATION, 2020-2029 (USD THOUSAND)

TABLE 69 U.S. INFECTIOUS DISEASES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY TYPE, 2020-2029 (USD THOUSAND)

TABLE 70 U.S. POINT OF CARE IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY TYPE, 2020-2029 (USD THOUSAND)

TABLE 71 U.S. IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY DEPLOYMENT MODE, 2020-2029 (USD THOUSAND)

TABLE 72 U.S. IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY ORGANIZATION SIZE, 2020-2029 (USD THOUSAND)

TABLE 73 U.S. REGULATORY AFFAIRS OUTSOURCING MARKET, BY STAGE, 2020-2029 (USD THOUSAND)

TABLE 74 U.S. IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY CLASS, 2020-2029 (USD THOUSAND)

TABLE 75 U.S. IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY END USER, 2020-2029 (USD THOUSAND)

TABLE 76 U.S. MEDICAL DEVICE COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY ORGANIZATION SIZE, 2020-2029 (USD THOUSAND)

TABLE 77 U.S. MEDICAL DEVICE COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY SERVICE, 2020-2029 (USD THOUSAND)

TABLE 78 U.S. PHARMACEUTICAL COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY ORGANIZATION SIZE, 2020-2029 (USD THOUSAND)

TABLE 79 U.S. PHARMACEUTICAL COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY SERVICE, 2020-2029 (USD THOUSAND)

TABLE 80 U.S. BIOTECHNOLOGY COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY ORGANIZATION SIZE, 2020-2029 (USD THOUSAND)

TABLE 81 U.S. BIOTECHNOLOGY COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY SERVICE, 2020-2029 (USD THOUSAND)

TABLE 82 CANADA IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY SERVICE, 2020-2029 (USD THOUSAND)

TABLE 83 CANADA IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY INDICATION, 2020-2029 (USD THOUSAND)

TABLE 84 CANADA INFECTIOUS DISEASES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY TYPE, 2020-2029 (USD THOUSAND)

TABLE 85 CANADA POINT OF CARE IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY TYPE, 2020-2029 (USD THOUSAND)

TABLE 86 CANADA IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY DEPLOYMENT MODE, 2020-2029 (USD THOUSAND)

TABLE 87 CANADA IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY ORGANIZATION SIZE, 2020-2029 (USD THOUSAND)

TABLE 88 CANADA REGULATORY AFFAIRS OUTSOURCING MARKET, BY STAGE, 2020-2029 (USD THOUSAND)

TABLE 89 CANADA IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY CLASS, 2020-2029 (USD THOUSAND)

TABLE 90 CANADA IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY END USER, 2020-2029 (USD THOUSAND)

TABLE 91 CANADA MEDICAL DEVICE COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY ORGANIZATION SIZE, 2020-2029 (USD THOUSAND)

TABLE 92 CANADA MEDICAL DEVICE COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY SERVICE, 2020-2029 (USD THOUSAND)

TABLE 93 CANADA PHARMACEUTICAL COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY ORGANIZATION SIZE, 2020-2029 (USD THOUSAND)

TABLE 94 CANADA PHARMACEUTICAL COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY SERVICE, 2020-2029 (USD THOUSAND)

TABLE 95 CANADA BIOTECHNOLOGY COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY ORGANIZATION SIZE, 2020-2029 (USD THOUSAND)

TABLE 96 CANADA BIOTECHNOLOGY COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY SERVICE, 2020-2029 (USD THOUSAND)

TABLE 97 MEXICO IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY SERVICE, 2020-2029 (USD THOUSAND)

TABLE 98 MEXICO IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY INDICATION, 2020-2029 (USD THOUSAND)

TABLE 99 MEXICO INFECTIOUS DISEASES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY TYPE, 2020-2029 (USD THOUSAND)

TABLE 100 MEXICO POINT OF CARE IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY TYPE, 2020-2029 (USD THOUSAND)

TABLE 101 MEXICO IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY DEPLOYMENT MODE, 2020-2029 (USD THOUSAND)

TABLE 102 MEXICO IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY ORGANIZATION SIZE, 2020-2029 (USD THOUSAND)

TABLE 103 MEXICO REGULATORY AFFAIRS OUTSOURCING MARKET, BY STAGE, 2020-2029 (USD THOUSAND)

TABLE 104 MEXICO IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY CLASS, 2020-2029 (USD THOUSAND)

TABLE 105 MEXICO IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY END USER, 2020-2029 (USD THOUSAND)

TABLE 106 MEXICO MEDICAL DEVICE COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY ORGANIZATION SIZE, 2020-2029 (USD THOUSAND)

TABLE 107 MEXICO MEDICAL DEVICE COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY SERVICE, 2020-2029 (USD THOUSAND)

TABLE 108 MEXICO PHARMACEUTICAL COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY ORGANIZATION SIZE, 2020-2029 (USD THOUSAND)

TABLE 109 MEXICO PHARMACEUTICAL COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY SERVICE, 2020-2029 (USD THOUSAND)

TABLE 110 MEXICO BIOTECHNOLOGY COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY ORGANIZATION SIZE, 2020-2029 (USD THOUSAND)

TABLE 111 MEXICO BIOTECHNOLOGY COMPANIES IN IVD REGULATORY AFFAIRS OUTSOURCING MARKET, BY SERVICE, 2020-2029 (USD THOUSAND)

图片列表

FIGURE 1 NORTH AMERICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET: SEGMENTATION

FIGURE 2 NORTH AMERICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET: DATA TRIANGULATION

FIGURE 3 NORTH AMERICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET: DROC ANALYSIS

FIGURE 4 NORTH AMERICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET: NORTH AMERICA VS REGIONAL MARKET ANALYSIS

FIGURE 5 NORTH AMERICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 NORTH AMERICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 7 NORTH AMERICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET: DBMR MARKET POSITION GRID

FIGURE 8 NORTH AMERICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET: VENDOR SHARE ANALYSIS

FIGURE 9 NORTH AMERICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET: END USER COVERAGE GRID

FIGURE 10 NORTH AMERICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET: SEGMENTATION

FIGURE 11 RISE IN THE PREVALENCE OF CHRONIC DISEASES ACROSS IS EXPECTED TO DRIVE NORTH AMERICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET IN THE FORECAST PERIOD OF 2022 TO 2029

FIGURE 12 SERVICE SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF NORTH AMERICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET IN 2022 & 2029

FIGURE 13 ASIA-PACIFIC IS EXPECTED TO DOMINATE AND IS THE FASTEST GROWING REGION IN THE NORTH AMERICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET IN THE FORECAST PERIOD OF 2022 TO 2029

FIGURE 14 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES FOR NORTH AMERICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET

FIGURE 15 MULTIPLE CHRONIC CONDITIONS AMONG PEOPLE AGED 65 AND ABOVE IN EUROPEAN REGION (2017)

FIGURE 16 NORTH AMERICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET: BY SERVICE, 2021

FIGURE 17 NORTH AMERICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET: BY INDICATION, 2021

FIGURE 18 NORTH AMERICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET: BY CLASS, 2021

FIGURE 19 NORTH AMERICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET: BY DEPLOYMENT MODE, 2021

FIGURE 20 NORTH AMERICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET: BY ORGANIZATION SIZE, 2021

FIGURE 21 NORTH AMERICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET: BY STAGE, 2021

FIGURE 22 NORTH AMERICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET: BY END USER, 2021

FIGURE 23 NORTH AMERICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET: SNAPSHOT (2021)

FIGURE 24 NORTH AMERICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET: BY COUNTRY (2021)

FIGURE 25 NORTH AMERICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET: BY COUNTRY (2022 & 2029)

FIGURE 26 NORTH AMERICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET: BY COUNTRY (2021 & 2029)

FIGURE 27 NORTH AMERICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET: BY SERVICE (2022-2029)

FIGURE 28 NORTH AMERICA IVD REGULATORY AFFAIRS OUTSOURCING MARKET: COMPANY SHARE 2021 (%)

查看详细信息

研究方法

数据收集和基准年分析是使用具有大样本量的数据收集模块完成的。该阶段包括通过各种来源和策略获取市场信息或相关数据。它包括提前检查和规划从过去获得的所有数据。它同样包括检查不同信息源中出现的信息不一致。使用市场统计和连贯模型分析和估计市场数据。此外，市场份额分析和关键趋势分析是市场报告中的主要成功因素。要了解更多信息，请请求分析师致电或下拉您的询问。

DBMR 研究团队使用的关键研究方法是数据三角测量，其中包括数据挖掘、数据变量对市场影响的分析和主要（行业专家）验证。数据模型包括供应商定位网格、市场时间线分析、市场概览和指南、公司定位网格、专利分析、定价分析、公司市场份额分析、测量标准、全球与区域和供应商份额分析。要了解有关研究方法的更多信息，请向我们的行业专家咨询。

可定制

Data Bridge Market Research 是高级形成性研究领域的领导者。我们为向现有和新客户提供符合其目标的数据和分析而感到自豪。报告可定制，包括目标品牌的价格趋势分析、了解其他国家的市场（索取国家列表）、临床试验结果数据、文献综述、翻新市场和产品基础分析。目标竞争对手的市场分析可以从基于技术的分析到市场组合策略进行分析。我们可以按照您所需的格式和数据样式添加您需要的任意数量的竞争对手数据。我们的分析师团队还可以为您提供原始 Excel 文件数据透视表（事实手册）中的数据，或者可以帮助您根据报告中的数据集创建演示文稿。

常见问题

预测2022至2029年的预测期间,市场将以何种增长率增长?

北美IVD管理事务外包市场预计将在2022至2029年的预测期内以13.4%的CAGR增长.

未来的市场价值是什么?

北美IVD管理事务外包市场预计在2022至2029年的预测期间将达到779,587.15万美元。

市场增长繁荣的重要因素是什么?

推动IVD监管事务外包市场增长的主要因素是发展基于项目的支持,导致组织之间达成长期外包协议,以及各种体外诊断设备的技术进步.

谁是在市场上经营的主要角色?

报告的主要参与者是IVD监管事务外包市场:Freyr Solutions、AX Source、LORENZ生命科学集团、PPD公司(Thremofisher Science Inc.的子公司)、Promedica International、加利福尼亚公司、Assent合规公司、MakroCare、EMERGO、ICON、Parexel International公司、CRITERIUM、INC.、Groupe Proparmama Group、VCLS、Labcorp Drugyp、WoXi AppTec、Charles River Laboratories、Genpat、Medpache、监管合规联营公司、RQM+、Saraca解决方案私人有限公司、PBC BioMed、Dor药品服务公司、Qserve、Mdiconsults等。